Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
CYAD

Overview Financials Analysis Smart Money

Celyad Oncology S.A.

CYAD · NASDAQ

Analyze with AI

Filings1

Total reported value$153.9K

Manager	Shares	Value	Change
RS INVESTMENT MANAGEMENT CO LLC	327.4K	$153.9K	-0.9%

SymbolCYAD

Market Cap$14.2M

IPO Date2015-06-19

CEOGeorges Rawadi

Employees35

SectorHealthcare

IndustryBiotechnology

CountryBE

ExchangeNASDAQ Global Market

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

GD Culture Group Limited

GDC

$5.26

+51.59%

Peers

Imunon, Inc.

IMNN · NASDAQ

$3.75

-1.06%

SQZ Biotechnologies Company

SQZB · OTC

$0.024

+0.00%

Reunion Neuroscience Inc.

REUN · NASDAQ

$1.12

-0.89%

Axcella Health Inc.

AXLA · NASDAQ

$4.58

+0.00%

Kineta, Inc.

KA · NASDAQ

$0.5746

-30.77%

Talphera, Inc.

TLPH · NASDAQ

$1.10

-0.90%

AlphaTON Capital Corp.

ATON · NASDAQ

$0.722

+1.68%

TuHURA Biosciences, Inc.

HURA · NASDAQ

$0.8186

-7.69%

Gelesis Holdings, Inc.

GLS · NYSE

$0.1586

+0.00%

Notable Labs, Ltd.

NTBL · NASDAQ

$0.2479

-27.68%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.